Home > Insider Trading > Filing (0001104659-21-083613)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	Services-Commercial Physical & Biological Research (8731)	463640387

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1624044	L Christopher Gaenzle	C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612	Evp, Cao & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-17	4,213	$95.94	38,713	No	4	M	Direct
Common Stock	Acquisiton	2021-06-17	18,958	$101.42	57,671	No	4	M	Direct
Common Stock	Acquisiton	2021-06-17	4,326	$103.30	61,997	No	4	M	Direct
Common Stock	Disposition	2021-06-17	1,300	$167.40	60,697	No	4	S	Direct
Common Stock	Disposition	2021-06-17	13,391	$168.06	47,306	No	4	S	Direct
Common Stock	Disposition	2021-06-17	12,114	$169.41	35,192	No	4	S	Direct
Common Stock	Disposition	2021-06-17	692	$169.75	34,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-17	4,213	$0.00	4,213	$95.94
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-17	18,958	$0.00	18,958	$101.42
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-17	4,326	$0.00	4,326	$103.30

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,666	2029-08-13	No	4	M	Direct
37,500	2028-08-10	No	4	M	Direct
17,114	2030-06-01	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.72 to $167.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.72 to $168.67, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.73 to $169.70, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.73 to $169.79, inclusive.
The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
The option vests in four equal annual installments of 18,750 beginning on August 10, 2019.
The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.